Off and On Again Story of Ponatinib in CMLOff and On Again Story of Ponatinib in CML

Dr. Michael Deininger reviews the data from ASH 2013 on ponatinib in chronic myeloid leukemia, and discusses the drug's future in view of the recent FDA decision to suspend approval. Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news